Breaking News

Financial Report: PAREXEL 1Q11

Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%).

Related CONTENT

11.02.10

PAREXEL 1Q11

1Q Revenues: $342.3 million (+11%)

1Q Earnings: $17.8 million (+44%)

Comments: Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%). PAREXEL Consulting & Medical Communications Services (PCMS) accounted for $28.3 million (-2%). Perceptive Informatics, Inc. (PII) Service revenue was $35.8 million (+25%). The Americas accounted for $132.9 million (+31%), Europe, Middle East & Africa, $125.5 million (-3%), and Asia/Pacific, $37.4 million (+31%).

Suggested For You

Clinical Trials are Transforming Right Before Our Eyes

Clinical Trials are Transforming Right Before Our Eyes

Clinical Ink Adds Executives

Clinical Ink Adds Executives

Thermo Fisher Acquires PPD for $17.4B

Thermo Fisher Acquires PPD for $17.4B

Intravacc Completes Project for Provention Bio’s Vax Candidate

Intravacc Completes Project for Provention Bio’s Vax Candidate

Parexel Appoints Chief Patient Officer

Parexel Appoints Chief Patient Officer

SGS Initiates U.S. COVID-19 Clinical Trials

SGS Initiates U.S. COVID-19 Clinical Trials

CROS NT Expands Medidata Pact

CROS NT Expands Medidata Pact

KCR Expands U.S. Presence

KCR Expands U.S. Presence

CROs & Next-Gen Drug Development

CROs & Next-Gen Drug Development

How to Maximize Potential and Sidestep Pitfalls of MAPs

How to Maximize Potential and Sidestep Pitfalls of MAPs

INC Research Makes Executive Appointments

INC Research Makes Executive Appointments

PAREXEL Appoints SVP, CFO

PAREXEL Appoints SVP, CFO

Financial Report: PAREXEL

Financial Report: PAREXEL

PAREXEL Expands Senior Leadership Team

PAREXEL Expands Senior Leadership Team

Related Online Exclusives

Clinical Trials | Information Technology

Clinical Trials are Transforming Right Before Our Eyes

Decentralized clinical trials, an innovation just a short time ago, are now mainstream.
Kristin Brooks, Managing Editor, Contract Pharma 09.03.21
Clinical Trials | Information Technology | Promotions & Moves

Clinical Ink Adds Executives

CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso to manage eSource platforms.
Kristin Brooks 05.04.21
Breaking News | CRO News | Industry News

Thermo Fisher Acquires PPD for $17.4B

Further expands service offering to pharma and biotech customers.
Tim Wright, Editor, Contract Pharma 04.15.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News

Intravacc Completes Project for Provention Bio’s Vax Candidate

Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.
Contract Pharma Staff 01.19.21
Breaking News | Clinical Trials | Promotions & Moves

Parexel Appoints Chief Patient Officer

Demonstrates the company’s commitment to elevating the patient perspective.
Contract Pharma Staff 01.06.21